
Mechanistic basis for unexpected bioavailability enhancement of polyelectrolyte complexes incorporating BCS class III drugs and carrageenans
Keywords: ﺳﺪﯾﻢ دودﺳﯿﻞ ﺳﻮﻟﻔﺎت; SDS, sodium dodecyl sulfate; TPGS, tocopheryl polyethylene glycol succinate; PGP, P-Glycoprotein; TJs, tight junctions; API, active pharmaceutical ingredient; PECs, polyelectrolyte complexes; KBR, Krebs-Ringer-Bicarbonate-buffer. pH 7.4; R, transsegmental